Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
The New England Journal of Medicine
|
May 27, 2026
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Corina E Gonzalez, Anita Fletcher, Tonya L Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Miriam E Mossoba, David C Halverson, Roger Kurlander, et al.
The Lancet. Haematology
|
March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.
Journal of Translational Medicine
|
December 2, 2015
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Paolo A Ascierto, Michael Atkins, Carlo Bifulco, et al.
Journal of Translational Medicine
|
October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
Blood
|
May 23, 2022
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
Haneen Shalabi, Haiying Qin, Angela Su, et al.
Cancer Cell
|
December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
The New England Journal of Medicine
|
May 27, 2026
Resolution of PML after Treatment with Virus-Specific T Cells and HCT
Corina E Gonzalez, Anita Fletcher, Tonya L Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses
Miriam E Mossoba, David C Halverson, Roger Kurlander, et al.
The Lancet. Haematology
|
March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.
Journal of Translational Medicine
|
December 2, 2015
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Paolo A Ascierto, Michael Atkins, Carlo Bifulco, et al.
Journal of Translational Medicine
|
October 29, 2014
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
Paolo A Ascierto, Antonio M Grimaldi, Ana Carrizosa Anderson, et al.
Blood
|
May 23, 2022
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
Haneen Shalabi, Haiying Qin, Angela Su, et al.
Cancer Cell
|
December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Page
of 10